PortfoliosLab logo
Teladoc Health, Inc. (TDOC)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US87918A1051

CUSIP

87918A105

IPO Date

Jul 1, 2015

Highlights

Market Cap

$1.25B

EPS (TTM)

-$5.91

PEG Ratio

-1.01

Total Revenue (TTM)

$2.55B

Gross Profit (TTM)

$1.70B

EBITDA (TTM)

-$734.57M

Year Range

$6.35 - $15.21

Target Price

$9.18

Short %

12.92%

Short Ratio

3.65

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

Teladoc Health, Inc. (TDOC) returned -21.78% year-to-date (YTD) and -40.50% over the past 12 months.


TDOC

YTD

-21.78%

1M

-1.80%

6M

-22.97%

1Y

-40.50%

5Y*

-48.31%

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.77%

1M

7.44%

6M

-5.60%

1Y

8.37%

5Y*

14.12%

10Y*

10.46%

*Annualized

Monthly Returns

The table below presents the monthly returns of TDOC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202511.77%-5.91%-16.74%-9.67%-1.11%-21.78%
2024-9.84%-22.39%0.13%-15.56%-11.84%-12.99%-3.58%-23.97%28.03%-1.96%33.11%-24.12%-57.82%
202324.31%-9.90%-2.23%2.43%-12.74%9.37%17.58%-23.95%-17.89%-11.03%9.67%18.80%-8.88%
2022-16.46%-1.04%-4.98%-53.20%0.98%-2.58%10.96%-15.71%-18.38%16.92%-3.81%-17.05%-74.24%
202131.94%-16.20%-17.79%-5.17%-12.63%10.43%-10.73%-2.71%-12.19%17.96%-32.31%-9.31%-54.08%
202021.49%22.86%24.05%6.18%5.75%9.64%24.52%-9.23%1.65%-10.39%1.18%0.60%138.84%
201929.51%0.25%-13.61%2.30%2.18%14.26%2.76%-15.18%17.00%13.11%9.32%-0.02%68.89%
20187.32%7.22%0.50%6.70%18.37%14.05%3.10%29.57%11.35%-19.70%-9.94%-20.62%42.24%
201721.21%10.25%13.38%-0.80%23.39%13.40%-5.48%2.29%-1.19%-0.30%12.25%-6.06%111.21%
2016-9.58%-14.84%-30.59%26.56%-5.93%40.16%8.86%2.24%2.69%-11.25%12.92%-10.08%-8.13%
201510.77%-18.47%-13.40%-11.75%8.03%-15.48%-36.98%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of TDOC is 16, meaning it’s performing worse than 84% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of TDOC is 1616
Overall Rank
The Sharpe Ratio Rank of TDOC is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of TDOC is 1414
Sortino Ratio Rank
The Omega Ratio Rank of TDOC is 1717
Omega Ratio Rank
The Calmar Ratio Rank of TDOC is 2222
Calmar Ratio Rank
The Martin Ratio Rank of TDOC is 1010
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Teladoc Health, Inc. (TDOC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Teladoc Health, Inc. Sharpe ratios as of May 11, 2025 (values are recalculated daily):

  • 1-Year: -0.69
  • 5-Year: -0.74
  • All Time: -0.21

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Teladoc Health, Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History


Teladoc Health, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Teladoc Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Teladoc Health, Inc. was 97.79%, occurring on Apr 21, 2025. The portfolio has not yet recovered.

The current Teladoc Health, Inc. drawdown is 97.59%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.79%Feb 9, 20211054Apr 21, 2025
-72.72%Aug 5, 2015162Mar 28, 2016310Jun 19, 2017472
-50.34%Oct 1, 201859Dec 24, 2018259Jan 6, 2020318
-30.86%Aug 5, 202069Nov 10, 202049Jan 22, 2021118
-24.19%Sep 15, 201744Nov 15, 201710Nov 30, 201754

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Teladoc Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Teladoc Health, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 38.9% positive surprise.


-20.00-15.00-10.00-5.000.0020212022202320242025
-0.22
-0.36
Actual
Estimate

Valuation

The Valuation section provides an overview of how Teladoc Health, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for TDOC compared to other companies in the Health Information Services industry. TDOC currently has a PEG ratio of -1.0. This PEG ratio is negative, which typically signals that the company's earnings are expected to decline. A negative PEG is not considered meaningful for valuation purposes.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for TDOC relative to other companies in the Health Information Services industry. Currently, TDOC has a P/S ratio of 0.5. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for TDOC in comparison with other companies in the Health Information Services industry. Currently, TDOC has a P/B value of 0.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items